Core Laboratories (CLB) Cash from Financing Activities (2022 - 2025)
Core Laboratories' Cash from Financing Activities history spans 4 years, with the latest figure at -$7.1 million for Q4 2025.
- For Q4 2025, Cash from Financing Activities rose 63.24% year-over-year to -$7.1 million; the TTM value through Dec 2025 reached -$31.3 million, up 31.99%, while the annual FY2025 figure was -$31.3 million, 31.99% up from the prior year.
- Cash from Financing Activities reached -$7.1 million in Q4 2025 per CLB's latest filing, up from -$16.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $6.1 million in Q1 2023 to a low of -$19.4 million in Q4 2024.
- Average Cash from Financing Activities over 4 years is -$8.1 million, with a median of -$6.6 million recorded in 2023.
- Peak YoY movement for Cash from Financing Activities: plummeted 32464.29% in 2024, then skyrocketed 76.62% in 2025.
- A 4-year view of Cash from Financing Activities shows it stood at -$12.6 million in 2022, then crashed by 46.97% to -$18.5 million in 2023, then dropped by 4.84% to -$19.4 million in 2024, then surged by 63.24% to -$7.1 million in 2025.
- Per Business Quant, the three most recent readings for CLB's Cash from Financing Activities are -$7.1 million (Q4 2025), -$16.5 million (Q3 2025), and -$3.2 million (Q2 2025).